A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation
Public ClinicalTrials.gov record NCT04201418. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4 Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of Hereditary Transthyretin-Mediated (ATTRv) Amyloidosis With a V122I or T60A Mutation
Study identification
- NCT ID
- NCT04201418
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Alnylam Pharmaceuticals
- Industry
- Enrollment
- 67 participants
Conditions and interventions
Interventions
- Patisiran Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 17, 2019
- Primary completion
- May 23, 2022
- Completion
- May 23, 2022
- Last update posted
- Jun 5, 2022
2019 – 2022
United States locations
- U.S. sites
- 27
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Trial Site | Los Angeles | California | 90095 | — |
| Clinical Trial Site | San Diego | California | 92103 | — |
| Clinical Trial Site | Aurora | Colorado | 80045 | — |
| Clinical Trial Site | Farmington | Connecticut | 06030 | — |
| Clinical Trial Site | Jacksonville | Florida | 32224 | — |
| Clinical Trial Site | Tampa | Florida | 33609 | — |
| Clinical Trial Site | Braselton | Georgia | 30517 | — |
| Clinical Trial Site | Macon | Georgia | 31201 | — |
| Clinical Trial Site | Chicago | Illinois | 60611 | — |
| Clinical Trial Site | Chicago | Illinois | 60612 | — |
| Clinical Trial Site | Boston | Massachusetts | 02111 | — |
| Clinical Trial Site | Detroit | Michigan | 48202 | — |
| Clinical Trial Site | Jackson | Mississippi | 39216 | — |
| Clinical Trial Site | Kansas City | Missouri | 64111 | — |
| Clinical Trial Site | Omaha | Nebraska | 68198 | — |
| Clinical Trial Site | Chapel Hill | North Carolina | 27599 | — |
| Clinical Trial Site | Charlotte | North Carolina | 28207 | — |
| Clinical Trial Site | Columbus | Ohio | 43210 | — |
| Clinical Trial Site | Allentown | Pennsylvania | 18103 | — |
| Clinical Trial Site | Bethlehem | Pennsylvania | 18015 | — |
| Clinical Trial Site | Lancaster | Pennsylvania | 17602 | — |
| Clinical Trial Site | Pittsburgh | Pennsylvania | 15212 | — |
| Clinical Trial Site | Pittsburgh | Pennsylvania | 15232 | — |
| Clinical Trial Site | Germantown | Tennessee | 38138 | — |
| Clinical Trial Site | Austin | Texas | 78756 | — |
| Clinical Trial Site | San Antonio | Texas | 78229 | — |
| Clinical Trial Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04201418, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 5, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04201418 live on ClinicalTrials.gov.